.svg)
Frontier Biotechnology
Synthetic BiologyCell and Gene TherapyAntibody and Nucleic Acid DrugsVaccines
World Biotechnology Frontier and Industry Development Conference
Serving research institutes, pharmaceutical companies, industrial parks and investors as an international platform for biotechnology innovation and industrial collaboration.
The World Biotechnology Frontier and Industry Development Conference is an international professional congress and exhibition in the biotechnology field held in Chengdu, China, combining an academic conference with an industry exhibition to connect the full chain of academic innovation, technology transfer, industrial application and international cooperation.
The congress features sectors including frontier biotechnology, biomanufacturing industry technology, agricultural biotechnology, laboratory instruments and consumables, research achievement transformation and industry support services, with exhibits and topics covering synthetic biology, cell and gene therapy, stem cells and regenerative medicine, antibody, peptide and nucleic acid drugs, vaccines, biochips, AI biomedicine and innovative drugs, as well as life science analytical instruments, cell culture and separation and purification equipment, reagents and consumables, and cleanroom engineering and GMP support equipment.
The congress features a main forum on the global biotechnology frontier and bioeconomy development, along with 8 parallel sub-forums including synthetic biology and green biomanufacturing, and cell and gene therapy innovation and clinical translation. It also hosts a frontier technology achievement exhibition, supply-demand matchmaking meetings and an innovation and entrepreneurship competition roadshow, creating matchmaking settings between research achievements and industry needs.
The congress targets researchers, pharmaceutical companies, CDMOs/CROs, instrument and reagent companies, universities and research institutes, biomedical industrial parks, venture capital institutions and government industry departments, supported by visits to biomedical industrial parks in the Chengdu-Chongqing area, and is suitable for academic exchange, achievement release, business negotiation and investment matchmaking.
Area
Exhibitors
Visitors
It takes place from 19 to 21 May 2027.
Daily from 9:00 to 17:00 on 19, 20 and 21 May 2027.
At the Chengdu Century City New International Convention and Exhibition Center in Chengdu, China.
Admission is for trade visitors only; a free visitor badge is available through online pre-registration or on-site registration, and on-site registration requires a business card and a completed visitor registration form in exchange for the badge.
Most foreign visitors need a visa for mainland China and should prepare a passport valid for more than six months, a completed visa application form and one passport photograph.
The programme includes one opening plenary forum and eight parallel sub-forums covering synthetic biology and green bio-manufacturing, cell and gene therapy, AI and digital biology, innovative drugs and mRNA, agricultural biotechnology, and investment and technology transfer.
World Biotechnology Frontier and Industry Development Conference
Serving research institutes, pharmaceutical companies, industrial parks and investors as an international platform for biotechnology innovation and industrial collaboration.
The World Biotechnology Frontier and Industry Development Conference is an international professional congress and exhibition in the biotechnology field held in Chengdu, China, combining an academic conference with an industry exhibition to connect the full chain of academic innovation, technology transfer, industrial application and international cooperation.
The congress features sectors including frontier biotechnology, biomanufacturing industry technology, agricultural biotechnology, laboratory instruments and consumables, research achievement transformation and industry support services, with exhibits and topics covering synthetic biology, cell and gene therapy, stem cells and regenerative medicine, antibody, peptide and nucleic acid drugs, vaccines, biochips, AI biomedicine and innovative drugs, as well as life science analytical instruments, cell culture and separation and purification equipment, reagents and consumables, and cleanroom engineering and GMP support equipment.
The congress features a main forum on the global biotechnology frontier and bioeconomy development, along with 8 parallel sub-forums including synthetic biology and green biomanufacturing, and cell and gene therapy innovation and clinical translation. It also hosts a frontier technology achievement exhibition, supply-demand matchmaking meetings and an innovation and entrepreneurship competition roadshow, creating matchmaking settings between research achievements and industry needs.
The congress targets researchers, pharmaceutical companies, CDMOs/CROs, instrument and reagent companies, universities and research institutes, biomedical industrial parks, venture capital institutions and government industry departments, supported by visits to biomedical industrial parks in the Chengdu-Chongqing area, and is suitable for academic exchange, achievement release, business negotiation and investment matchmaking.
Area
Exhibitors
Visitors
It takes place from 19 to 21 May 2027.
Daily from 9:00 to 17:00 on 19, 20 and 21 May 2027.
At the Chengdu Century City New International Convention and Exhibition Center in Chengdu, China.
Admission is for trade visitors only; a free visitor badge is available through online pre-registration or on-site registration, and on-site registration requires a business card and a completed visitor registration form in exchange for the badge.
Most foreign visitors need a visa for mainland China and should prepare a passport valid for more than six months, a completed visa application form and one passport photograph.
The programme includes one opening plenary forum and eight parallel sub-forums covering synthetic biology and green bio-manufacturing, cell and gene therapy, AI and digital biology, innovative drugs and mRNA, agricultural biotechnology, and investment and technology transfer.
Coming Soon
19940848151
support@expofinder.com
Ongoing